A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate

A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer

NCT01171417 ·Status: COMPLETED

Quality of Life in Chinese Postmenopausal HR(+) Early Breast Cancer (EBC) Patients During Adjuvant Aromatase Inhibitors(AIs) Treatment

NCT01144572 ·Status: COMPLETED

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

NCT01758146 ·Status: UNKNOWN ·Phase: PHASE3

Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole

NCT00316836 ·Status: COMPLETED

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer

NCT00902954 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide

NCT03004534 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Zoledronic Acid - Letrozole Adjuvant Synergy Trial (ZFAST) - Cancer Treatment Related Bone Loss in Postmenopausal Women With Estrogen Receptor Positive and/or Progesterone Receptor Positive Breast Cancer Receiving Adjuvant Hormonal Therapy

NCT00050011 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer

NCT00082277 ·Status: COMPLETED ·Phase: PHASE4

Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)

NCT06195202 ·Status: RECRUITING

Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing

NCT00828854 ·Status: COMPLETED ·Phase: PHASE2

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

NCT00421447 ·Status: COMPLETED

Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women

NCT05053841 ·Status: COMPLETED ·Phase: PHASE2

Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer

NCT01654367 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Clinical Study of Adjuvant Therapy on Post-menopausal Women With Breast Cancer Under the Guidance of the Results of Preoperative Endocrinotherapy

NCT01613560 ·Status: UNKNOWN ·Phase: PHASE2

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

NCT00293540 ·Status: COMPLETED ·Phase: PHASE3

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

NCT00963417 ·Status: COMPLETED ·Phase: NA

Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole

NCT00623519 ·Status: COMPLETED

A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)

NCT04576455 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence

NCT01081509 ·Status: COMPLETED

Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer

NCT00003771 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]AZD9833

NCT05364255 ·Status: COMPLETED ·Phase: PHASE1

Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer

NCT00107263 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole and Letrozole

NCT00762294 ·Status: COMPLETED

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

NCT02097459 ·Status: UNKNOWN ·Phase: PHASE3

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer

NCT02769104 ·Status: UNKNOWN ·Phase: PHASE3